Home » SMITH & NEPHEW DROPS DERMAGRAFT AFTER FDA REBUFF
SMITH & NEPHEW DROPS DERMAGRAFT AFTER FDA REBUFF
Medical devices maker Smith & Nephew Plc recently said it was dropping its Dermagraft skin product after failing to win U.S. regulatory approval for its use in treating venous leg ulcers. The news is the second setback in rapid succession for the British company, which cut its full-year sales and profit forecasts last month in the face of competition from rivals and disruption at U.S. hospitals due to Hurricane Katrina.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May